Inhibited fat accumulation and body weight, hyperlipidemia; reduced LPS level; decreased levels of TNF-α and IL-1β; increased acetate and butyrate production; inhibited LPS/TLR4/NF-κB signaling pathway. The gene discussed is NFKB1; the disease is hyperlipidemia.